#below-sidebar .right .fl{--wpr-bg-d3d1cef1-4f45-4a4a-abd4-442bfeff3573: url('https://www.nagpurtoday.in/wp-content/uploads/2021/07/all-icons.png');}#below-sidebar .right .go{--wpr-bg-2bd60739-6858-4453-8d41-d89f5670dd4c: url('https://www.nagpurtoday.in/wp-content/uploads/2021/07/all-icons.png');}#below-sidebar .right .fb{--wpr-bg-cf323134-cfde-4419-b63b-123e80d99579: url('https://www.nagpurtoday.in/wp-content/uploads/2021/07/all-icons.png');}#below-sidebar .right .tw{--wpr-bg-fb4d779e-f0b7-4229-98fc-03875621a0d8: url('https://www.nagpurtoday.in/wp-content/uploads/2021/07/all-icons.png');}.topsocials ul.toprsocial li a.fl{--wpr-bg-2aca1e4a-b9c7-4018-8a60-b96bdd7d0dd8: url('https://www.nagpurtoday.in/wp-content/uploads/2021/07/all-icons.png');}.topsocials ul.toprsocial li a.go{--wpr-bg-77df00ce-1f8c-4b6d-8de8-e7f75d51612e: url('https://www.nagpurtoday.in/wp-content/uploads/2021/07/all-icons.png');}.topsocials ul.toprsocial li a.fb{--wpr-bg-4e8b4e00-1bb4-48df-b0f0-91d5af97344b: url('https://www.nagpurtoday.in/wp-content/uploads/2021/07/all-icons.png');}.topsocials ul.toprsocial li a.tw{--wpr-bg-852fc788-8c37-4039-b585-6d5ac1f7e897: url('https://www.nagpurtoday.in/wp-content/uploads/2021/07/all-icons.png');}.topsocials .searchform{--wpr-bg-3ad898d1-264a-49f1-b0ff-7322f4862ee3: url('https://www.nagpurtoday.in/wp-content/uploads/2021/08/serchbg-1.png');}.nw-banner{--wpr-bg-8b734284-6071-4fe5-a158-53282a2ee81a: url('https://www.transparenttextures.com/patterns/carbon-fibre.png');}

Published On : Wed, Nov 3rd, 2021

By Nagpur Today Nagpur News

Covaxin gets WHO nod for emergency use listing

Watch Live News

Bharat Biotech’s Covaxin gets WHO approval for Emergency Use Listing.

Covaxin is one of the vaccines that have received emergency use authorisation from Indias drug regulator and is being used in the nationwide inoculation programme, along with Covishield and Sputnik V.

On October 18, the WHO had said that it was expecting one additional piece of information from Bharat Biotech on Covaxin, which is being examined by WHOs experts for grant of Emergency Use Listing (EUL).

The WHO has so far approved Covid vaccines developed by Pfizer-BioNTech, US pharma majors Johnson & Johnson, Moderna, Chinas Sinopharm and Oxford-AstraZeneca for emergency use.